EG-011 CAS 2377113-41-0
Introduction:Basic information about EG-011 CAS 2377113-41-0, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
EG-011 Basic information
| Product Name: | EG-011 |
| Synonyms: | EG-011;Pyrido[3,2-d]pyrimidine-2,4(1H,3H)-dione, 3-[1-(1-oxo-2-propen-1-yl)-3-piperidinyl]-1-[(4-phenoxyphenyl)methyl]- |
| CAS: | 2377113-41-0 |
| MF: | C28H26N4O4 |
| MW: | 482.53 |
| EINECS: | |
| Product Categories: | |
| Mol File: | 2377113-41-0.mol |
EG-011 Chemical Properties
| Boiling point | 710.1±70.0 °C(Predicted) |
| density | 1.312±0.06 g/cm3(Predicted) |
| pka | 2.25±0.20(Predicted) |
| form | Solid |
| color | White to off-white |
Safety Information
| Uses | EG-011 is the first-in-class and potent Wiskott-Aldrich syndrome protein (WASP) activator. EG-011 activates the auto-inhibited form of WASP with strong actin polymerization. EG-011 has selective anti-tumor activity in lymphomas[1][2][3]. |
| in vivo | EG-011 (200 mg/kg; i.p.; 5 days per week) delays tumor growth (Day 6, Day 7, Day 9) and tumor weight in female NOD-SCID mice with the MCL REC-1 cell line. EG-011-treated tumors are 2.2-fold smaller than controls (P<0.001)[1]. |
| References | [1] E. Gaudio, et al. EG-011 IS A NOVEL SMALL MOLECULE WITH IN VITRO AND IN VIVOANTI-TUMOR ACTIVITY AGAINST LYMPHOMA. Hematological OncologyVolume 37: 15th International Conference on Malignant Lymphoma Palazzo dei Congressi, Lugano, Switzerland, 18-22 June, 2019. [2] Filippo Spriano, et al. Abstract 1817: EG-011 is a first-in-class Wiskott-Aldrich syndrome protein (WASp) activator with anti-tumor activity. Cancer Res (2022) 82 (12_Supplement): 1817. [3] F. Spriano, et al. The first-in-class WASP activator EG-011 is active in lymphoma and multiple myeloma cell lines resistant to FDA approved compounds. European Journal of Cancer 174S1 (2022) S3-S128. |
